Oxular is actively partnering with industry peers to utilize the potential of our technology across multiple modalities and indications.
Our drug administration technology enables routine administration to deliver drugs to specific back-of-eye tissues, including the suprachoroidal spaces.
Our drug formulations are designed to suit the unique ocular environments into which they are delivered, resulting in better kinetics and therapeutic benefits. They can provide treatment effects lasting up to 12 months from a single administration.
If you would like to discuss a potential partnership with Oxular, please contact us via the form linked below.